Klacid Baby (Clarithromycin)

Clarithromycin binds to the 50S subunit of bacterial ribosomes, blocking peptide chain elongation during protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect that allows the immune system to clear the infection.

The exact dose of Klacid Baby is determined by the prescribing clinician based on the child’s age, weight, infection type, and severity. Healthcare providers calculate the appropriate amount and frequency according to approved pediatric dosing guidelines.

Clarithromycin is classified as Pregnancy Category B, indicating no evidence of risk in animal studies and insufficient human data. It may be used during pregnancy only if clearly needed. Limited data suggest it is excreted in breast milk, so breastfeeding decisions should be made with a healthcare professional.

To request Klacid Baby, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Clarithromycin offers a broader spectrum against certain Gram‑positive organisms and better tissue penetration than erythromycin, while maintaining a similar safety profile. Compared with azithromycin, clarithromycin has a shorter half‑life and may require more frequent dosing, but it is often preferred for infections where higher intracellular concentrations are needed.

Klacid Baby should be stored at ambient temperature, below 25 °C. Keep the suspension in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain stability.

Klacid Baby is supplied as an oral suspension. The dose is measured with a calibrated syringe or dosing spoon and given by mouth, usually with or without food as directed by the prescriber. Proper technique ensures accurate dosing and improves tolerability.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, significant liver enzyme elevations indicating hepatotoxicity, and QT interval prolongation that can lead to cardiac arrhythmias. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Klacid Baby should be avoided in children with a known hypersensitivity to clarithromycin or other macrolide antibiotics. It is also contraindicated in patients with a history of severe QT prolongation or those taking medications that strongly interact with CYP3A4 without appropriate monitoring.